source
- Gene-editing biotech Scribe Therapeutics files for Nasdaq IPOScribe Therapeutics, a California-based biotechnology startup developing genetic medicines for cardiometabolic disorders, announced plans to go public on the Nasdaq under the ticker SCTX. The comp…
- FDA CDER appoints veteran GLP-1 reviewer Lisa Yanoff as acting deputy directorActing FDA CDER director Michael Davis promoted Lisa Yanoff to the role of acting deputy director of the Center for Drug Evaluation and Research. Yanoff is a long‑time FDA employee with deep exper…